David L. Fitzgerald

Array ( [id] => 3765385 [patent_doc_number] => 05756097 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Lymphokine activated effector cells for antibody-dependent cellular cytotoxicity (ADCC) treatment of cancer and other diseases' [patent_app_type] => 1 [patent_app_number] => 8/237595 [patent_app_country] => US [patent_app_date] => 1994-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11307 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756097.pdf [firstpage_image] =>[orig_patent_app_number] => 237595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3664410 [patent_doc_number] => 05668104 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Hematopoietic stem cell growth-promoting compositions containing a fibroblast-derived fragment of fibronectin and a growth factor, and methods employing them in vitro or in vivo' [patent_app_type] => 1 [patent_app_number] => 8/142449 [patent_app_country] => US [patent_app_date] => 1994-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6985 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/668/05668104.pdf [firstpage_image] =>[orig_patent_app_number] => 142449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729246 [patent_doc_number] => 05635370 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'DNA encoding BEHAB, a brain hyaluronan-binding protein, and recombinant expression systems for production of BEHAB polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/225477 [patent_app_country] => US [patent_app_date] => 1994-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 7676 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635370.pdf [firstpage_image] =>[orig_patent_app_number] => 225477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3490433 [patent_doc_number] => 05560915 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-01 [patent_title] => 'Composition for treating IgE mediated allergies comprising substance P and allergen' [patent_app_type] => 1 [patent_app_number] => 8/225474 [patent_app_country] => US [patent_app_date] => 1994-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8434 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/560/05560915.pdf [firstpage_image] =>[orig_patent_app_number] => 225474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3759209 [patent_doc_number] => 05851824 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Human calcium channel .alpha.-1C/.alpha.-1D, .alpha.-2, .beta.-1, and .gamma.subunits and cells expressing the DNA' [patent_app_type] => 1 [patent_app_number] => 8/223305 [patent_app_country] => US [patent_app_date] => 1994-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 37180 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/851/05851824.pdf [firstpage_image] =>[orig_patent_app_number] => 223305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695065 [patent_doc_number] => 05595888 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Recombinant methods of making gamma interferon compositions' [patent_app_type] => 1 [patent_app_number] => 8/221542 [patent_app_country] => US [patent_app_date] => 1994-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 7209 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/595/05595888.pdf [firstpage_image] =>[orig_patent_app_number] => 221542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772957 [patent_doc_number] => 05817485 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Nucleic acids and cells for recombinant production of fibroblast growth factor-10' [patent_app_type] => 1 [patent_app_number] => 8/207412 [patent_app_country] => US [patent_app_date] => 1994-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8711 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817485.pdf [firstpage_image] =>[orig_patent_app_number] => 207412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3868377 [patent_doc_number] => 05763210 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Recombinant production of interferon-gamma binding proteins' [patent_app_type] => 1 [patent_app_number] => 8/205358 [patent_app_country] => US [patent_app_date] => 1994-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 9314 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763210.pdf [firstpage_image] =>[orig_patent_app_number] => 205358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3663828 [patent_doc_number] => 05625035 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Erythropoietin binding protein from mammalian serum' [patent_app_type] => 1 [patent_app_number] => 8/202717 [patent_app_country] => US [patent_app_date] => 1994-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9962 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/625/05625035.pdf [firstpage_image] =>[orig_patent_app_number] => 202717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3551954 [patent_doc_number] => 05573939 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-12 [patent_title] => 'DNA encoding mammalian retinol binding protein receptor, and corresponding vectors and transformed cells' [patent_app_type] => 1 [patent_app_number] => 8/200807 [patent_app_country] => US [patent_app_date] => 1994-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 5778 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/573/05573939.pdf [firstpage_image] =>[orig_patent_app_number] => 200807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3560533 [patent_doc_number] => 05525488 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-11 [patent_title] => 'Nucleic acid encoding the mature .alpha. chain of inhibin and method for synthesizing polypeptides using such nucleic acid' [patent_app_type] => 1 [patent_app_number] => 8/197792 [patent_app_country] => US [patent_app_date] => 1994-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 19491 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/525/05525488.pdf [firstpage_image] =>[orig_patent_app_number] => 197792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3482333 [patent_doc_number] => 05457182 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-10 [patent_title] => 'FK-506 cytosolic binding protein, FKBP12.6' [patent_app_type] => 1 [patent_app_number] => 8/197795 [patent_app_country] => US [patent_app_date] => 1994-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16520 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/457/05457182.pdf [firstpage_image] =>[orig_patent_app_number] => 197795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3597357 [patent_doc_number] => 05559011 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-24 [patent_title] => 'Nucleic acids encoding membrane-associated immunogens of mycobacterial and corresponding probes, vectors, and transformed host cells' [patent_app_type] => 1 [patent_app_number] => 8/192632 [patent_app_country] => US [patent_app_date] => 1994-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 9135 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/559/05559011.pdf [firstpage_image] =>[orig_patent_app_number] => 192632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3835041 [patent_doc_number] => 05846757 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Human calcium channel .alpha..sub.1, .alpha..sub.2, and .beta. subunits and assays using them' [patent_app_type] => 1 [patent_app_number] => 8/193078 [patent_app_country] => US [patent_app_date] => 1994-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34767 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846757.pdf [firstpage_image] =>[orig_patent_app_number] => 193078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3825181 [patent_doc_number] => 05738849 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => 'Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them' [patent_app_type] => 1 [patent_app_number] => 8/192299 [patent_app_country] => US [patent_app_date] => 1994-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 39959 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/738/05738849.pdf [firstpage_image] =>[orig_patent_app_number] => 192299 [rel_patent_id] =>[rel_patent_doc_number] =>)